Logo image of IREN

IREN LTD (IREN) Stock Fundamental Analysis

NASDAQ:IREN - Nasdaq - AU0000185993 - Common Stock - Currency: USD

19.69  +0.61 (+3.2%)

After market: 19.97 +0.28 (+1.42%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IREN. IREN was compared to 283 industry peers in the Software industry. Both the profitability and financial health of IREN have multiple concerns. IREN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IREN had negative earnings in the past year.
In the past year IREN has reported a negative cash flow from operations.
In the past 5 years IREN always reported negative net income.
Of the past 5 years IREN 4 years had a positive operating cash flow.
IREN Yearly Net Income VS EBIT VS OCF VS FCFIREN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

With a Return On Assets value of -1.79%, IREN perfoms like the industry average, outperforming 56.89% of the companies in the same industry.
IREN's Return On Equity of -2.50% is fine compared to the rest of the industry. IREN outperforms 60.78% of its industry peers.
Industry RankSector Rank
ROA -1.79%
ROE -2.5%
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IREN Yearly ROA, ROE, ROICIREN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IREN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IREN Yearly Profit, Operating, Gross MarginsIREN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

3

2. Health

2.1 Basic Checks

IREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IREN has been increased compared to 1 year ago.
Compared to 1 year ago, IREN has an improved debt to assets ratio.
IREN Yearly Shares OutstandingIREN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
IREN Yearly Total Debt VS Total AssetsIREN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 4.11 indicates that IREN is not in any danger for bankruptcy at the moment.
The Altman-Z score of IREN (4.11) is better than 66.08% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that IREN is not too dependend on debt financing.
IREN has a better Debt to Equity ratio (0.00) than 67.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.11
ROIC/WACCN/A
WACC11.42%
IREN Yearly LT Debt VS Equity VS FCFIREN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.46 indicates that IREN may have some problems paying its short term obligations.
IREN's Current ratio of 0.46 is on the low side compared to the rest of the industry. IREN is outperformed by 91.52% of its industry peers.
A Quick Ratio of 0.46 indicates that IREN may have some problems paying its short term obligations.
IREN has a Quick ratio of 0.46. This is amonst the worse of the industry: IREN underperforms 90.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
IREN Yearly Current Assets VS Current LiabilitesIREN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.75% over the past year.
Looking at the last year, IREN shows a very strong growth in Revenue. The Revenue has grown by 149.98%.
IREN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 188.02% yearly.
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%172.49%

3.2 Future

Based on estimates for the next years, IREN will show a very strong growth in Earnings Per Share. The EPS will grow by 211.02% on average per year.
The Revenue is expected to grow by 74.50% on average over the next years. This is a very strong growth
EPS Next Y178.24%
EPS Next 2Y439.19%
EPS Next 3Y211.02%
EPS Next 5YN/A
Revenue Next Year162.87%
Revenue Next 2Y120.06%
Revenue Next 3Y74.5%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IREN Yearly Revenue VS EstimatesIREN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
IREN Yearly EPS VS EstimatesIREN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

IREN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 22.51 indicates a rather expensive valuation of IREN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IREN indicates a somewhat cheap valuation: IREN is cheaper than 73.50% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of IREN to the average of the S&P500 Index (35.34), we can say IREN is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 22.51
IREN Price Earnings VS Forward Price EarningsIREN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IREN Per share dataIREN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IREN's earnings are expected to grow with 211.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y439.19%
EPS Next 3Y211.02%

More info and screens

0

5. Dividend

5.1 Amount

IREN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IREN LTD

NASDAQ:IREN (8/15/2025, 8:00:02 PM)

After market: 19.97 +0.28 (+1.42%)

19.69

+0.61 (+3.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners63.43%
Inst Owner ChangeN/A
Ins Owners6.09%
Ins Owner Change45.46%
Market Cap4.42B
Analysts82.22
Price Target21.6 (9.7%)
Short Float %14.73%
Short Ratio1.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)171.1%
Min EPS beat(2)-22.73%
Max EPS beat(2)364.93%
EPS beat(4)1
Avg EPS beat(4)-232.62%
Min EPS beat(4)-1085.5%
Max EPS beat(4)364.93%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-8.9%
Max Revenue beat(2)1.42%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-8.9%
Max Revenue beat(4)1.42%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.93%
PT rev (3m)3.67%
EPS NQ rev (1m)-5.49%
EPS NQ rev (3m)-40.59%
EPS NY rev (1m)0%
EPS NY rev (3m)-85.87%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-7.24%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)-4.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.51
P/S 11.65
P/FCF N/A
P/OCF N/A
P/B 3.1
P/tB 3.1
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)0.87
Fwd EY4.44%
FCF(TTM)-2.56
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS1.69
BVpS6.35
TBVpS6.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.79%
ROE -2.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 110.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z 4.11
F-Score4
WACC11.42%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)123.51%
Cap/Sales(5y)130.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y178.24%
EPS Next 2Y439.19%
EPS Next 3Y211.02%
EPS Next 5YN/A
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%172.49%
Revenue Next Year162.87%
Revenue Next 2Y120.06%
Revenue Next 3Y74.5%
Revenue Next 5YN/A
EBIT growth 1Y44.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5284.11%
EBIT Next 3Y380.54%
EBIT Next 5YN/A
FCF growth 1Y18.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y771.34%
OCF growth 3Y210.56%
OCF growth 5YN/A